Financials data is unavailable for this security.
View more
Year on year VBI Vaccines Inc grew revenues 702.40% from 1.08m to 8.68m while net income improved from a loss of 113.30m to a smaller loss of 92.84m.
Gross margin | -24.06% |
---|---|
Net profit margin | -881.79% |
Operating margin | -766.73% |
Return on assets | -81.40% |
---|---|
Return on equity | -424.67% |
Return on investment | -171.57% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at VBI Vaccines Inc fell by 38.94m. Cash Flow from Financing totalled 22.70m or 261.44% of revenues. In addition the company used 60.88m for operations while cash used for investing totalled 867.00k.
Cash flow per share | -4.15 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.2166 |
---|---|
Tangible book value per share | -1.68 |
More ▼
Balance sheet in USDView more
Current ratio | 0.3397 |
---|---|
Quick ratio | 0.2116 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.13 |
More ▼